Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation

2. Preface

3. Executive Summary

4. Impact of COVID-19 on Asia-Pacific Bioinformatics Market

5. Asia-Pacific Bioinformatics Market Outlook, 2016-2026F
5.1. Market Size & Analysis
5.1.1. By Revenues
5.2. Market Share & Analysis
5.2.1. By Product & Services
5.2.1.1. Platforms
5.2.1.1.1. Sequence Analysis Platforms
5.2.1.1.2. Sequence Alignment Platforms
5.2.1.1.3. Structural & Functional Analysis Platforms
5.2.1.1.4. Sequence Manipulation Platforms
5.2.1.1.5. Other
5.2.1.2. Knowledge Management Tools
5.2.1.2.1. Generalized Knowledge Management Tools
5.2.1.2.2. Specialized Knowledge Management Tools
5.2.1.3. Services
5.2.1.3.1. Data Analysis Services
5.2.1.3.2. Database Management Services
5.2.1.3.3. Other
5.2.2. By Application
5.2.2.1. Genomics
5.2.2.2. Metabolomics
5.2.2.3. Chemoinformatics & Drug Design
5.2.2.4. Transcriptomics
5.2.2.5. Proteomics
5.2.2.6. Other (Molecular Medicine, Preventive Medicine, etc.)
5.2.3. By Type of Sector
5.2.3.1. Animal Biotechnology
5.2.3.2. Environmental Biotechnology
5.2.3.2.1. Waste Clean-up/ Bioremediation
5.2.3.2.2. Alternative Energy Sources
5.2.3.3. Agriculture Biotechnology
5.2.3.3.1. Nutritional Quality Improvement
5.2.3.3.2. Biodiversity Informatics
5.2.3.3.3. Improvement of Plant Resistance
5.2.3.3.4. Pest Resistance
5.2.3.3.5. Crop Yield Improvement
5.2.3.4. Forensic Biotechnology
5.2.3.5. Medical Biotechnology
5.2.3.5.1. Reproductive Biotechnology
5.2.3.5.2. Gene Therapy
5.2.3.5.3. Molecular Medicine
5.2.3.5.4. Clinical Diagnostics
5.2.3.5.5. Drug Development
5.2.3.6. Academics
5.2.3.7. Others
5.2.4. By Country
5.2.4.1. China
5.2.4.2. India
5.2.4.3. Japan
5.2.4.4. Australia
5.2.4.5. South Korea
5.2.4.6. Taiwan
5.2.4.7. Southeast Asia
5.2.4.8. Others
5.2.5. By Competitors
5.2.5.1. Competition Characteristics
5.2.5.2. Market Share & Analysis
5.2.5.3. Competitive Metrix

6. China Bioinformatics Market Outlook, 2016-2026F
6.1. Market Size & Analysis
6.1.1. By Revenues
6.2. Market Share & Analysis
6.2.1. By Product & Services
6.2.2. By Application
6.2.3. By Type of Sector

7. India Bioinformatics Market Outlook, 2016-2026F
7.1. Market Size & Analysis
7.1.1. By Revenues
7.2. Market Share & Analysis
7.2.1. By Product & Services
7.2.2. By Application
7.2.3. By Type of Sector

8. Japan Bioinformatics Market Outlook, 2016-2026F
8.1. Market Size & Analysis
8.1.1. By Revenues
8.2. Market Share & Analysis
8.2.1. By Product & Services
8.2.2. By Application
8.2.3. By Type of Sector
8.2.4. Australia Bioinformatics Market Outlook, 2016-2026F
8.3. Market Size & Analysis
8.3.1. By Revenues
8.4. Market Share & Analysis
8.4.1. By Product & Services
8.4.2. By Application
8.4.3. By Type of Sector
8.4.4. South Korea Bioinformatics Market Outlook, 2016-2026F
8.5. Market Size & Analysis
8.5.1. By Revenues
8.6. Market Share & Analysis
8.6.1. By Product & Services
8.6.2. By Application
8.6.3. By Type of Sector

9. Taiwan Bioinformatics Market Outlook, 2016-2026F
9.1. Market Size & Analysis
9.1.1. By Revenues
9.2. Market Share & Analysis
9.2.1. By Product & Services
9.2.2. By Application
9.2.3. By Type of Sector

10. Southeast Asia Bioinformatics Market Outlook, 2016-2026F
10.1. Market Size & Analysis
10.1.1. By Revenues
10.2. Market Share & Analysis
10.2.1. By Product & Services
10.2.2. By Application
10.2.3. By Type of Sector

11. Asia-Pacific Bioinformatics Market Trends & Insights

12. Asia-Pacific Bioinformatics Market Dynamics
12.1. Drivers
12.2. Challenges
12.3. Impact Analysis

13. Asia-Pacific Bioinformatics Market Hotspots & Opportunities

14. Asia-Pacific Bioinformatics Market Regulations & Policy

15. Key Strategic Imperatives for Success and Growth

16. Competition Outlook
16.1. Competition Matrix
16.1.1. Target Product/ Services
16.1.2. Target Markets
16.1.3. Target End Users
16.1.4. Research & Development
16.1.5. Strategic Alliances
16.1.6. Strategic Initiatives
16.2. Company Profile
16.2.1. Thermo Fisher Scientific
16.2.2. Eurofins Scientific
16.2.3. Illumina
16.2.4. Perkinelmer, Inc.
16.2.5. Qiagen Bioinformatics
16.2.6. Agilent Technologies
16.2.7. Dnastar
16.2.8. Waters Corporation
16.2.9. Sophia Genetics
16.2.10. Partek
16.2.11. Biomax Informatics AG
16.2.12. Wuxi Nextcode
16.2.13. Beijing Genomics Institute (BGI)

17. Disclaimer